Shanghai Yizhong Pharmaceutical Co. Ltd. Class ASSE: 688091

Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical Insurance

· Issued by Shanghai Yizhong Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical Insurance

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis